Vyome Holdings, Inc. (NASDAQ:HIND) Short Interest Down 45.9% in June

Vyome Holdings, Inc. (NASDAQ:HIND) was the target of a significant drop in short interest in the month of June. As of June 30th, there was short interest totaling 35,140 shares, a drop of 45.9% from the June 15th total of 64,989 shares. Based on an average daily volume of 20,610 shares, the days-to-cover ratio is presently 1.7 days. Approximately 0.7% of the company’s stock are sold short.

Hedge Funds Weigh In On Vyome

A hedge fund recently bought a new stake in Vyome stock. Geode Capital Management LLC purchased a new position in shares of Vyome Holdings, Inc. (NASDAQ:HIND) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 11,934 shares of the company’s stock, valued at approximately $41,000. Geode Capital Management LLC owned about 0.21% of Vyome at the end of the most recent reporting period. Institutional investors and hedge funds own 22.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on HIND. Litchfield Hills Research began coverage on shares of Vyome in a report on Monday, May 4th. They set a “buy” rating on the stock. Zacks Research upgraded shares of Vyome to a “hold” rating in a research note on Wednesday, May 6th. Finally, Weiss Ratings upgraded Vyome from a “sell (e)” rating to a “sell (e+)” rating in a research note on Friday, May 1st. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $15.00.

Vyome Trading Down 3.5%

NASDAQ:HIND traded down $0.08 during mid-day trading on Thursday, hitting $2.19. The stock had a trading volume of 6,650 shares, compared to its average volume of 410,424. Vyome has a twelve month low of $1.75 and a twelve month high of $18.60. The stock has a 50-day simple moving average of $2.17 and a two-hundred day simple moving average of $2.45. The company has a market capitalization of $15.37 million, a PE ratio of -0.18 and a beta of 1.49.

Vyome (NASDAQ:HIND) last posted its quarterly earnings results on Tuesday, May 12th. The company reported ($0.15) EPS for the quarter. The business had revenue of $0.03 million for the quarter. Sell-side analysts predict that Vyome will post -0.6 EPS for the current fiscal year.

About Vyome

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.